Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	188,515,591 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	95,532,998 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	L.L
R03AL02	COMBIVENT	B	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide - 500mcg/2.5ml		Inhaltion solution with nebuliser	745,833 L.L
R03AK06	CYVAX	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,710,712 L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	102,120,767 L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	L.L
A07BA51	CARBOSYLANE	B	Simethicone (blue-red) - 45mg (blue-red), Activated charcoal (blue-red) - 140mg (blue-red)		Capsule	585,915 L.L
B05XA03	CHLORURE DE SODIUM 0.9 pour cent Renaudin	G	Sodium chloride - 0.9%	0.90%	Injectable solution	385,683 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.90%	Injectable solution	1,104,639 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.90%	Injectable solution	705,517 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	629,916 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	744,140 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	769,337 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	744,140 L.L
B05D	CAPD/DPCA 2Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Glucose monohydrate - 16.5g/l		Injectable solution	735,741 L.L
B05D	CAPD/DPCA 3Solution for peritoneal dialysis	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 42.50g/l, Glucose monohydrate - 46.75g/l		Injectable solution	769,337 L.L
A06AB58	CITRAFLEET	G	Sodium picosulfate - 10mg/sachet, Magnesium oxide (light) - 3.5g/sachet, Citric acid (anhydrous) - 10.97g/sachet, Potassium - 195mg/sachet		Powder for solution	1,191,988 L.L
N03AG01	CONVULEX	G	Sodium valproate - 100mg/ml	100mg/ml	Injectable solution	4,441,399 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 300mg/ml	300mg/ml	Solution	1,018,633 L.L
N03AG01	CONVULEX RETARD	G	Sodium Valproate - 500mg	500mg	Tablet, prolonged release	423,310 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 50mg/ml	50mg/ml	Syrup	213,671 L.L
H01AC01	CINNATROPIN	BioTech	Somatropin recombinant - 10mg/1.5ml	10mg/1.5ml	Injectable solution	9,012,607 L.L
H01AC01	CINNATROPIN	BioTech	Somatropin recombinant - 10mg/1.5ml	10mg/1.5ml	Injectable solution	L.L
H01AC01	CINNATROPIN	BioTech	Somatropin recombinant - 5mg/1.5ml	5mg/1.5ml	Injectable solution	4,699,417 L.L
D06BA02	CREM-O-SULFA	G	Sulfathiazole - 5%	5%	Cream	202,216 L.L
G04BE08	CIALIS	B	Tadalafil - 20mg	20mg	Tablet, film coated	3,101,588 L.L
G04BE08	CIALIS	B	Tadalafil - 5mg	5mg	Tablet, film coated	6,512,261 L.L
H05AA02	CINNOPAR	BioTech	Teriparatide - 250mcg/ml	250mcg/ml	Injectable solution	15,275,833 L.L

...